Fruzsina Gyergyay

Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts

Gilles Vassal, M J Terrier-Lacombe, A.M Vénuat et al. · British Journal of Cancer · 1996 · 103 citations · Full text

Tumor Innervation, Glioma, Neuroblastoma Xenografts +8

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil

Erika Hitre, Barna Budai, Vilmos Adleff et al. · Pharmacogenetics and Genomics · 2005 · 69 citations

Medicine, Genetics, Genetic Epidemiology +12

Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice

C.L. van der Wilt, Jan van Laar, Fruzsina Gyergyay et al. · European Journal of Cancer · 1992 · 31 citations

Medicinal Chemistry, Biochemistry, Medicine +10

Influence of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracil.

Tanya Bagrij, Judit Kralovánszky, Fruzsina Gyergyay et al. · PubMed · 1993 · 29 citations

Bolus Injection, Gastrointestinal Pharmacology, Gastroenterology +17

Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouracil

Godefridus J. Peters, C.L. van der Wilt, Fruzsina Gyergyay et al. · International Journal of Radiation Oncology*Biology*Physics · 1992 · 26 citations

Health Sciences, Medicine, Pharmacology +10